Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb

Transplantation

Volumn 68, Issue 6, 1999, Pages 747-757

  Lu, Lina ^a   Li, Wei ^a   Zhong, Cuiping ^a   Qian, Shiguang ^a   Fung, John J ^a   Thomson, Angus W ^a,b   Starzl, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CD86 ANTIGEN; GLYCOPROTEIN GP 39; INTERLEUKIN 2; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CHIMERA; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD86; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; BONE MARROW CELLS; CD40 LIGAND; DENDRITIC CELLS; GRAFT SURVIVAL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEART TRANSPLANTATION; IMMUNOPHENOTYPING; INTERLEUKIN-4; LEUKOCYTE TRANSFUSION; LYMPHOID TISSUE; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING;

EID: 0033610269     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199909270-00006     Document Type: Article

References (58)

1. Starzl TE, Zinkernagel R. Antigen localization and migration in immunity and tolerance. N Engl J Med 1998; 339: 1905.
2. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet 1992; 1: 1579.
3. Starzl TE, Demetris AJ, Trucco M, et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology 1993; 17: 1127.
4. Starzl TE, Demetris AJ, Murase N, Trucco M, Thomson AW, Rao AS. The lost chord: microchimerism. Immunol Today 1996; 17: 577.
5. Ehl S, Aichele P, Ramseier H, et al. Antigen persistence and time point of T cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nature Med 1998; 4: 1015.
6. Demetris AJ, Murase N, Fujisaki S, Fung JJ, Rao AS, Starzl TE. Hematolymphoid cell trafficking, microchimerism, and GVHD reactions after liver, bone marrow, and heart transplantation. Transplant Proc 1993; 25: 3337.
7. Qian S, Demetris AJ, Murase N, Rao AS, Fung JJ, Starzl TE. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology 1994; 19: 916.
8. Lu L, Rudert WA, Qian S, et al. Growth of donor-derived dendritic cells from the bone marrow of murine liver allograft recipients in response to granulocyte/macrophage colony-stimulating factor. J Exp Med 1995; 182: 379.
9. Sun J, McCaughan GW, Gallagher ND, Sheil AGR, Bishop GA. Deletion of spontaneous rat liver allograft acceptance by donor irradiation. Transplantation 1995; 60: 233.
10. Murase N, Starzl TE, Tanabe M, et al. Variable chimerism, graft versus host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to Brown-Norway rats. Transplantation 1995; 60: 158.
11. Bishop GA, Sun J, DeCruz DJ, et al. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues. J Immunol 1996; 156: 4925.
12. Bishop GA, Sun JN, Sheil AGR, McCaughan GW. High-dose/ activation-associated tolerance. A mechanism for allograft tolerance. Transplantation 1997; 64: 1377.
13. Qian S, Lu L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts. J Immunol 1997; 158: 4654.
14. Meyer D, Baumgardt S, Loeffeler S, et al. Apoptosis of T lymphocytes in liver and/or small bowel allografts during tolerance induction. Transplantation 1998; 66: 1530.
15. Thomson AW, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells 1995; 13: 622.
16. Lu L, Li W, Fu F, et al. Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 1997; 64: 1808.
17. Rastellini C, Lu L, Ricordi C, Starzl TE, Rao AS, Thomson AW. GM-CSF stimulated hepatic dendritic cell progenitors prolong pancreatic islet allograft survival. Transplantation 1995; 60: 1366.
18. -) prolong cardiac allograft survival in non-immunosuppressed recipients. Transplantation 1996; 62: 659.
19. Inaba K, Inaba M, Romani N, et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 1992; 176: 1693.
20. Lu L, Woo J, Rao AS, et al. Propagation of dendritic cell progenitors from normal mouse liver using GM-CSF and their maturational development in the presence of type-1 collagen. J Exp Med 1994; 179: 1823.
21. Lu L, Qian S, Hershberger P, Rudert WA, Lynch DH and Thomson AW. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 1997; 158: 5676.
22. Thomson AW, Lu L, Subbotin VM, et al. In vitro propagation and homing of liver-derived dendritic cell progenitors to lymphoid tissues of allogeneic recipients. Transplantation 1995; 59: 544.
23. -) induce alloantigen-specific hyporesponsiveness in murine T lymphocytes. Transplantation 1995; 60: 1539.
24. Durie FH, Foy TM, Masters SR, Laman JE, Noelle RJ: The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15: 406.
25. Hancock WW, Sayegh MH, Zheng X-G, Peach R, Linsley PS, Turka LA. Costimulatory function and expression of CD40 ligand, CD80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci USA 1996; 93: 13967.
26. Niimi M, Pearson TC, Larsen CP, et al. The role of the CD40 pathway in alloantigen-induced hyporesponsiveness in vivo. J Immunol 1998; 161: 5331.
27. Larsen CP, Alexander DZ, Hollenbaugh D, et al. CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation 1996; 61: 4.
28. Murase N, Starzl TE, Ye Q, et al. Multilineage hematopoietic reconstitution of supralethally irradiated rats by syngeneic whole organ transplantation: with particular reference to the liver. Transplantation 1996; 61: 1.
29. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nature Med 1996; 2: 198.
30. Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today 1997; 18: 14.
31. Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kundig T, Hengartner H. Antigen localization regulates immune responses in a dose- and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 1997; 156: 199.
32. Ohashi PS, Oehen S, Buerki K, et al. Ablation of "tolerance" and induction of diabetes by viruses infection in viral antigen transgenic mice. Cell 1991; 65: 305.
33. Ohashi PS, Oehen S, Aichele P, et al. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-α. J Immunol 1993; 150: 5185.
34. Aust JB, Rogers W, Guttmann R. The antigen persistence concept of homograft tolerance: immunologic response to tumor and spleen cells following transfer, reimplantation and parabiosis. Ann Surg 1965; 162: 738.
35. Morecki S, Leshem B, Eid A, Slavin S. Alloantigen persistence in induction and maintenance of transplantation tolerance. J Exp Med 1987; 165: 1468.
36. Jenkins MR, Pardoll DM, Mizuguchi J, Chused TM, Schwartz RH. Molecular events in the induction of a nonresponsive state of interleukin-2 producing helper T lymphocyte clones. Proc Natl Acad Sci USA 1987; 84: 5409.
37. Cohn M. The wisdom of hindsight. Annu Rev Immunol 1994; 12: 1.
38. Janeway CA Jr, Bottomly K. Signals and signs for lymphocyte responses. Cell 1994; 76: 275.
39. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol 1994; 12: 991.
40. Schwartz RH. Models of T cell anergy: is there a common molecular mechanism? J Exp Med 1996; 184: 1.
41. Janeway CA, Travers P, Walport M, Capra JD. Immunobiology, the immune system in health and disease, 4th ed. New York: Garland Publishing, 1999: 272.
42. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 System of T cell costimulation. Annu Rev Immunol 1996; 14: 233.
43. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Annu Rev Immunol 1993; 10: 561.
44. Murase N, Demetris AJ, Woo J, et al. Graft versus host disease (GVHD) after BN to LEW compared to LEW to BN rat intestinal transplantation under FK 506. Transplantation 1993; 55: 1.
45. Wekerle T, Sayegh MH, Hill J, et al. Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med 1998; 187: 2037.
46. Effros RB, Pawelec G. Replicative senescence of T cells: does the Hayflick limit lead to immune exhaustion? Immunol Today 1997; 18: 450.
47. Dai Z, Konieczny BT, Baddourn PK, Lakkis FG. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2 deficient mice. J Immunol 1998; 161: 1659.
48. Konieczny BT, Dai Z, Elwood ET, et al. IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol 1998; 160: 2059.
49. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
50. Willerford DM, Chen J, Ferry JA, Davidson L, Ma A, Alt FW. Interleukin-2 receptor α-chain regulates the size and content of the peripheral lymphoid compartment. Immunity 1995; 3: 521.
51. Kneitz B, Herman T, Yonehara S, Schimpl A. Normal clonal expansion but impaired Fas-mediated cell death and anergy in IL-2-deficient mice. Eur J Immunol 1995; 25: 2572.
52. Van Parijs L, Biuckians A, Ibragimove A, Alt FW, Willerford D, Abbas AK. Functional responses and apoptosis of CD25 (IL-2Rα)-deficient T cells expressing a transgenic antigen receptor. J Immunol 1997; 158: 3738.
53. Rafaeli Y, Parijs LV, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 1998; 8: 615.
54. +T cells, interferon-gamma and CTLA4. J Clin Invest 1998; 101: 2446.
55. Parker DC, Greiner DL, Phillips NE, et al. Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci USA 1995; 92: 9560.
56. Buhlmann JE, Foy TM, Aruffo A, et al. In the absence of a CD40 signal, B cells are tolerogenic. Immunity 1995; 2: 645.
57. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
58. Zinkernagel RM. Immunology taught by viruses. Science 1996; 271: 173.